ARROWHEAD PHARMACEUTICALS, INC. (ARWR) Operating cash flow 2016–2025
ARROWHEAD PHARMACEUTICALS, INC. (ARWR) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
$179.6MFY2025 · since FY2016: -$64.4M → $179.6M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $179.6M | +138.8% |
| FY2024 | -$462.9M | -200.8% |
| FY2023 | -$153.9M | -13.0% |
| FY2022 | -$136.1M | -179.5% |
| FY2021 | $171.3M | +278.8% |
| FY2020 | -$95.8M | -155.4% |
| FY2019 | $173.0M | +466.4% |
| FY2018 | -$47.2M | -97.3% |
| FY2017 | -$23.9M | +62.8% |
| FY2016 | -$64.4M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More ARWR financial trends
ARWR RevenueARWR Net incomeARWR Net marginARWR Gross profitARWR Gross marginARWR Operating incomeARWR Operating marginARWR Free cash flowARWR Capital expendituresARWR Return on equityARWR Stock buybacksARWR Dividends paidARWR Total assetsARWR Total liabilitiesARWR Shareholders’ equityARWR overview →